These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 15761515)
21. Reduced antioxidant potential & sensitivity to oxidation in plasma low density lipoprotein fraction in type 2 diabetes mellitus patients. Ergüder IB; Karagenç N; Karaca L Indian J Med Res; 2006 Aug; 124(2):207-10. PubMed ID: 17015936 [TBL] [Abstract][Full Text] [Related]
22. Baseline diene conjugation in LDL lipids from newly diagnosed type 2 diabetic patients. Gavella M; Lipovac V; Car A; Vucic M Diabetes Metab; 2002 Nov; 28(5):391-6. PubMed ID: 12461476 [TBL] [Abstract][Full Text] [Related]
23. Impaired oxidant/antioxidant status and LDL-fatty acid composition are associated with increased susceptibility to peroxidation of LDL in diabetic patients. Merzouk S; Hichami A; Sari A; Madani S; Merzouk H; Yahia Berrouiguet A; Lenoir-Rousseaux JJ; Chabane-Sari N; Khan NA Gen Physiol Biophys; 2004 Dec; 23(4):387-99. PubMed ID: 15815074 [TBL] [Abstract][Full Text] [Related]
24. The evaluation of autoantibodies against oxidatively modified low-density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels, total antioxidant status, antioxidant enzyme activities, and endothelial dysfunction in patients with Behçet's disease. Orem A; Yandi YE; Vanizor B; Cimşit G; Uydu HA; Malkoç M Clin Biochem; 2002 May; 35(3):217-24. PubMed ID: 12074830 [TBL] [Abstract][Full Text] [Related]
25. Uptake of type III hypertriglyceridemic VLDL by macrophages is enhanced by oxidation, especially after remnant formation. Whitman SC; Miller DB; Wolfe BM; Hegele RA; Huff MW Arterioscler Thromb Vasc Biol; 1997 Sep; 17(9):1707-15. PubMed ID: 9327767 [TBL] [Abstract][Full Text] [Related]
26. Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Tsai EC; Hirsch IB; Brunzell JD; Chait A Diabetes; 1994 Aug; 43(8):1010-4. PubMed ID: 8039594 [TBL] [Abstract][Full Text] [Related]
27. Dietary selenium increases cellular glutathione peroxidase activity and reduces the enhanced susceptibility to lipid peroxidation of plasma and low-density lipoprotein in kidney transplant recipients. Hussein O; Rosenblat M; Refael G; Aviram M Transplantation; 1997 Mar; 63(5):679-85. PubMed ID: 9075838 [TBL] [Abstract][Full Text] [Related]
28. Enhanced susceptibility of low-density lipoprotein to in vitro oxidation in type 1 and type 2 diabetic patients. Beaudeux JL; Guillausseau PJ; Peynet J; Flourie F; Assayag M; Tielmans D; Warnet A; Rousselet F Clin Chim Acta; 1995 Aug; 239(2):131-41. PubMed ID: 8542651 [TBL] [Abstract][Full Text] [Related]
29. Increased susceptibility of LDL to in vitro oxidation in patients with insulin-dependent and non-insulin-dependent diabetes mellitus. Cominacini L; Garbin U; Pastorino AM; Fratta Pasini A; Campagnola M; De Santis A; Davoli A; Lo Cascio V Diabetes Res; 1994; 26(4):173-84. PubMed ID: 7648791 [TBL] [Abstract][Full Text] [Related]
30. Effect of improving glycemic control in patients with type 2 diabetes mellitus on low-density lipoprotein size, electronegative low-density lipoprotein and lipoprotein-associated phospholipase A2 distribution. Sánchez-Quesada JL; Vinagre I; de Juan-Franco E; Sánchez-Hernández J; Blanco-Vaca F; Ordóñez-Llanos J; Pérez A Am J Cardiol; 2012 Jul; 110(1):67-71. PubMed ID: 22481012 [TBL] [Abstract][Full Text] [Related]
31. [Oxidation of low-density lipoproteins. Correlation between reduced resistance in vitro and increased oxidation in vivo]. Maggi E; Falaschi F; Perani G; Frattoni A; Finardi G; Bellomo G Presse Med; 1995 Mar; 24(9):431-6. PubMed ID: 7746815 [TBL] [Abstract][Full Text] [Related]
32. Effects of short-term modest weight loss on fasting and post-prandial lipoprotein sub-fractions in type 2 diabetes mellitus patients. Ybarra J; James RW; Makoundou V; Bioletto S; Golay A Diabetes Metab; 2001 Dec; 27(6):701-8. PubMed ID: 11852380 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidant-antioxidant system in patients with psoriasis. Vanizor Kural B; Orem A; Cimşit G; Yandi YE; Calapoglu M Clin Chim Acta; 2003 Feb; 328(1-2):71-82. PubMed ID: 12559600 [TBL] [Abstract][Full Text] [Related]
34. Effects of phosphatidylserine on the oxidation of low density lipoprotein. Lou P; Gutman RL; Mao FW; Greenspan P Int J Biochem; 1994 Apr; 26(4):539-45. PubMed ID: 8013738 [TBL] [Abstract][Full Text] [Related]
35. Susceptibility of LDL to oxidation is not associated with the presence of coronary heart disease or renal dysfunction in NIDDM patients. Leinonen JS; Rantalaiho V; Solakivi T; Koivula T; Wirta O; Pasternack A; Alho H; Lehtimäki T Clin Chim Acta; 1998 Jul; 275(2):163-74. PubMed ID: 9721074 [TBL] [Abstract][Full Text] [Related]
36. Effects of a dietary oxidized fat on cholesterol in plasma and lipoproteins and the susceptibility of low-density lipoproteins to lipid peroxidation in guinea pigs fed diets with different concentrations of vitamins E and C. Eder K; Keller U; Brandsch C Int J Vitam Nutr Res; 2004 Jan; 74(1):11-20. PubMed ID: 15060896 [TBL] [Abstract][Full Text] [Related]
37. Electronegative low density lipoprotein subform is increased in patients with short-duration IDDM and is closely related to glycaemic control. Sánchez-Quesada JL; Pérez A; Caixàs A; Ordónmez-Llanos J; Carreras G; Payés A; González-Sastre F; de Leiva A Diabetologia; 1996 Dec; 39(12):1469-76. PubMed ID: 8960828 [TBL] [Abstract][Full Text] [Related]
38. Lipoprotein composition in NIDDM: effects of dietary oleic acid on the composition, oxidisability and function of low and high density lipoproteins. Dimitriadis E; Griffin M; Collins P; Johnson A; Owens D; Tomkin GH Diabetologia; 1996 Jun; 39(6):667-76. PubMed ID: 8781762 [TBL] [Abstract][Full Text] [Related]
39. Susceptibility of low-density lipoprotein to oxidation and circulating cell adhesion molecules in young healthy adult offspring of parents with type 2 diabetes. McSorley PT; Young IS; McEneny J; Fee H; McCance DR Metabolism; 2004 Jun; 53(6):755-9. PubMed ID: 15164324 [TBL] [Abstract][Full Text] [Related]
40. Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Bucala R; Makita Z; Koschinsky T; Cerami A; Vlassara H Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6434-8. PubMed ID: 8341651 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]